PHILADELPHIA, July 06, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) NASDAQ:CNTX, a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced that the Company was added to the small-cap Russel…
Vertex Sees Crinetics's Palsonify, Atumelnant Potentially Adding More Than $5B in Combined Annual Revenue
Vertex Pharmaceuticals Sees Crinetics Deal Immediately Helping Revenue Growth
ABIVAX/ Key word(s): Capital IncreaseAbivax Announces Closing of $920 Million Public Offering06.07.2026 / 22:05 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax Announces Closing of $920 Million Public OfferingPARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax…
Abivax Announces Closing of $920 Million Public OfferingPARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax SA (Euronext Paris:FR0012333284 – ABVX / NASDAQ:ABVX (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural r…
Breakthrough Therapy Designation granted for pevifoscorvir sodium in ChinaSOUTH SAN FRANCISCO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. NASDAQ:ALGS, a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver…
BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. NASDAQ:ELTX (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the closing of its previously announced registered direct offering…
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. NASDAQ:ECPG, an international specialty finance company, announced today that it will release its financial results for the second quarter 2026 on Wednesday, August 5, 2026, after the market closes. The Company will also host a…
CAMBRIDGE, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. NASDAQ:NTLA, a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on July 1, 2026, it awarded inducement grants to thir…
Highly experienced biotechnology executive and board member will assist Kalaris in achieving its next phase of growthBERKELEY HEIGHTS, N.J., July 06, 2026 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. NASDAQ:KLRS (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development…
Marie WashburnMIAMI, July 06, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. NASDAQ:LGVN a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Marie Washburn to the Compa…
CONSHOHOCKEN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL, a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on July 1, 2026 to seven n…
TORRANCE, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Navitas Semiconductor NASDAQ:NVTS today announced that it will report second quarter 2026 financial results on Monday, July 27, 2026, after the market close.Navitas’ President and CEO, Chris Allexandre, and CFO, Tonya Stevens, will host a conferen…
TORONTO, July 06, 2026 (GLOBE NEWSWIRE) -- McFarlane Lake Mining Limited (“McFarlane” or the “Company”) CSE:MLM, OTC:MLMLF, FRA:W2Z is pleased to announce that it has received exercise instructions from holders of an aggregate of 41,507,200 common share purchase warrants (the “Warrants”) at an exer…
PDUFA Target Action Date Set for April 24, 2027CANTON, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. NASDAQ:ORGO, a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that th…
MIAMI, July 06, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") NYSE:PFLT announced that it will report results for the third fiscal quarter ended June 30, 2026 on Monday, August 10, 2026 after the close of the financial markets.The Company will also host a conferenc…
MIAMI, July 06, 2026 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") NYSE:PNNT announced that it will report results for the third fiscal quarter ended June 30, 2026 on Monday, August 10, 2026 after the close of the financial markets.The Company will also host a conference ca…
CHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) NASDAQ:SPT, a leading AI-powered Social Intelligence Platform, today announced that it will report its financial results for the second quarter ending June 30, 2026 after market close on Thursday, August…
NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Valley National Bancorp NASDAQ:VLY, the holding company for Valley National Bank, announced that it will release its second quarter 2026 earnings before the market opens on Thursday, July 23, 2026.Valley’s CEO, Ira Robbins will host a conference call on T…
DENVER, July 6, 2026 /PRNewswire/ -- Vectra Bank Colorado is pleased to welcome Ty Aslin to the Executive team as Director of Commercial Banking. In this role, Ty will lead the organization focused on companies with revenues greater than $10MM. He will be responsible for market strategy, driving sa…
